SUPRIYA Stock Overview
Engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
No risks detected for SUPRIYA from our risk checks.
Supriya Lifescience Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹610.30 |
| 52 Week High | ₹675.00 |
| 52 Week Low | ₹234.90 |
| Beta | 0.36 |
| 11 Month Change | 10.30% |
| 3 Month Change | 54.88% |
| 1 Year Change | 118.63% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 56.15% |
Recent News & Updates
Supriya Lifescience (NSE:SUPRIYA) Has Announced That It Will Be Increasing Its Dividend To ₹0.80
Sep 08
We Think You Should Be Aware Of Some Concerning Factors In Supriya Lifescience's (NSE:SUPRIYA) Earnings
Jun 05Recent updates
Supriya Lifescience (NSE:SUPRIYA) Has Announced That It Will Be Increasing Its Dividend To ₹0.80
Sep 08We Think You Should Be Aware Of Some Concerning Factors In Supriya Lifescience's (NSE:SUPRIYA) Earnings
Jun 05Little Excitement Around Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings
May 10Lacklustre Performance Is Driving Supriya Lifescience Limited's (NSE:SUPRIYA) Low P/E
Feb 09Supriya Lifescience's (NSE:SUPRIYA) Shareholders May Want To Dig Deeper Than Statutory Profit
May 28Market Cool On Supriya Lifescience Limited's (NSE:SUPRIYA) Earnings Pushing Shares 27% Lower
May 07Shareholder Returns
| SUPRIYA | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -3.6% | -1.8% | 0.4% |
| 1Y | 118.6% | 61.0% | 43.9% |
Return vs Industry: SUPRIYA exceeded the Indian Pharmaceuticals industry which returned 61% over the past year.
Return vs Market: SUPRIYA exceeded the Indian Market which returned 43.9% over the past year.
Price Volatility
| SUPRIYA volatility | |
|---|---|
| SUPRIYA Average Weekly Movement | 7.4% |
| Pharmaceuticals Industry Average Movement | 6.1% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 3.8% |
Stable Share Price: SUPRIYA's share price has been volatile over the past 3 months.
Volatility Over Time: SUPRIYA's weekly volatility (7%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1987 | 448 | n/a | www.supriyalifescience.com |
Supriya Lifescience Limited engages in the research and development, manufacture, and sale of bulk drugs and pharmaceutical chemicals worldwide. The company offers active pharmaceuticals ingredients in anti-histamine, anti-allergic, anti-asthmatic, decongestant, analgesic/anti-pyretic/anesthetic, anti–hypertensive, anti-malarial products, vitamins, anti-malarial, and anti-gout areas. It also provides oncology, veterinary, and general category products.
Supriya Lifescience Limited Fundamentals Summary
| SUPRIYA fundamental statistics | |
|---|---|
| Market cap | ₹49.12b |
| Earnings (TTM) | ₹1.35b |
| Revenue (TTM) | ₹5.99b |
36.3x
P/E Ratio8.2x
P/S RatioIs SUPRIYA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SUPRIYA income statement (TTM) | |
|---|---|
| Revenue | ₹5.99b |
| Cost of Revenue | ₹2.23b |
| Gross Profit | ₹3.76b |
| Other Expenses | ₹2.41b |
| Earnings | ₹1.35b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 16.80 |
| Gross Margin | 62.75% |
| Net Profit Margin | 22.58% |
| Debt/Equity Ratio | 0.7% |
How did SUPRIYA perform over the long term?
See historical performance and comparison